Higher-grade brain tumors expressed more cannabinoid receptors, especially CB2 in blood vessels
Analysis of brain tumor tissue from 45 patients found increased CB1 receptor expression in tumor tissue and significantly higher CB2 receptor expression in blood vessels of grade III and IV astrocytomas compared to grade II and controls.
Quick Facts
What This Study Found
CB1 receptor expression was increased in tumor tissue across grades. CB2 receptor expression in blood vessels was significantly higher in grade III (anaplastic astrocytoma) and grade IV (glioblastoma) compared to grade II and control tissue, suggesting CB2 levels correlate with malignancy.
Key Numbers
45 patient tissue samples. CB2 was significantly higher in grade III-IV vs grade II blood vessels. CB1 was increased in tumor tissue overall. Three complementary methods confirmed findings.
How They Did This
Brain tumor tissue from 45 patients was analyzed using immunofluorescence, quantitative RT-PCR, and western blotting to measure CB1 and CB2 receptor expression in tumor tissue and blood vessels across astrocytoma grades.
Why This Research Matters
If cannabinoid receptor expression increases with tumor aggressiveness, these receptors could serve as both diagnostic markers for tumor grade and potential therapeutic targets for cannabinoid-based treatments.
The Bigger Picture
The CB2 finding in tumor blood vessels is particularly intriguing because high-grade astrocytomas depend on new blood vessel formation (angiogenesis), and CB2 may play a role in this process, making it a potential anti-angiogenic target.
What This Study Doesn't Tell Us
Relatively small sample from a single center. The study measured expression levels but did not test whether targeting these receptors affects tumor growth. Correlation between receptor expression and tumor grade does not prove a functional role.
Questions This Raises
- ?Could CB2-targeted therapies inhibit tumor angiogenesis in high-grade astrocytomas?
- ?Would cannabinoid receptor expression predict treatment response?
- ?Do other brain tumor types show similar receptor patterns?
Trust & Context
- Key Stat:
- CB2 in blood vessels significantly higher in grade III-IV tumors
- Evidence Grade:
- Moderate: original tissue analysis with three complementary methods, though limited by sample size and descriptive design.
- Study Age:
- Published in 2020 in Molecular Biology Reports.
- Original Title:
- The expression level of cannabinoid receptors type 1 and 2 in the different types of astrocytomas.
- Published In:
- Molecular biology reports, 47(7), 5461-5467 (2020)
- Authors:
- Hashemi, Mansoureh, Bashi, Senada, Zali, Alireza
- Database ID:
- RTHC-02603
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Does this mean cannabinoids can treat brain cancer?
This study only measured receptor levels, not treatment effects. The finding that receptors increase with tumor grade suggests they could be therapeutic targets, but clinical trials would be needed to determine if cannabinoid-based treatments actually help.
Why is CB2 in blood vessels important?
High-grade brain tumors grow aggressively partly because they recruit new blood vessels. The elevated CB2 expression in tumor blood vessels suggests the endocannabinoid system may be involved in this process, making it a potential target for anti-tumor therapy.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02603APA
Hashemi, Mansoureh; Bashi, Senada; Zali, Alireza. (2020). The expression level of cannabinoid receptors type 1 and 2 in the different types of astrocytomas.. Molecular biology reports, 47(7), 5461-5467. https://doi.org/10.1007/s11033-020-05636-8
MLA
Hashemi, Mansoureh, et al. "The expression level of cannabinoid receptors type 1 and 2 in the different types of astrocytomas.." Molecular biology reports, 2020. https://doi.org/10.1007/s11033-020-05636-8
RethinkTHC
RethinkTHC Research Database. "The expression level of cannabinoid receptors type 1 and 2 i..." RTHC-02603. Retrieved from https://rethinkthc.com/research/hashemi-2020-the-expression-level-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.